Absci (ABSI) EBITDA Margin Growth (1y) (2021 - 2026)
Absci (ABSI) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Absci |
1.13 Bn |
1.01 Bn |
- |
-1.17 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-1.17 Mn |
| Dec 31, 2025 |
-13,731.00 |
| Sep 30, 2025 |
-595,494.00 |
| Jun 30, 2025 |
-315,833.00 |
| Mar 31, 2025 |
22,503.00 |
| Dec 31, 2024 |
256,278.00 |
| Sep 30, 2024 |
135,525.00 |
| Jun 30, 2024 |
-70,823.00 |
| Mar 31, 2024 |
-61,923.00 |
| Dec 31, 2023 |
912,004.00 |
| Sep 30, 2023 |
-179,751.00 |
| Jun 30, 2023 |
162,689.00 |
| Mar 31, 2023 |
624,483.00 |
| Dec 31, 2022 |
-1.24 Mn |
| Sep 30, 2022 |
55,359.00 |
| Jun 30, 2022 |
2.74 Mn |
| Mar 31, 2022 |
82,891.00 |
| Dec 31, 2021 |
-358,345.00 |
| Sep 30, 2021 |
-129,141.00 |
| Jun 30, 2021 |
-2.98 Mn |
